Matches in SemOpenAlex for { <https://semopenalex.org/work/W2151403254> ?p ?o ?g. }
- W2151403254 endingPage "461" @default.
- W2151403254 startingPage "454" @default.
- W2151403254 abstract "Summary Vascular endothelial growth factor inhibitors ( VEGF i) are known to cause hypertension and renal injury that severely limits their use as an anticancer therapy. We hypothesized that the angiotensin‐converting enzyme inhibitor captopril not only prevents hypertension, but also decreases renal injury caused by the VEGF i sorafenib. Rats were administered sorafenib (20 mg/kg per day) alone or in combination with captopril (40 mg/kg per day) for 4 weeks. Sorafenib administration increased blood pressure, which plateaued by day 10. Concurrent treatment with captopril for 4 weeks resulted in a 30 mmHg decrease in blood pressure compared with sorafenib alone (155 ± 5 vs 182 ± 6 mmHg, respectively; P < 0.05). Furthermore, concurrent captopril treatment reduced albuminuria by 50% compared with sorafenib alone (20 ± 8 vs 42 ± 9 mg/day, respectively; P < 0.05) and reduced nephrinuria by eightfold (280 ± 96 vs 2305 ± 665 μg/day, respectively; P < 0.05). Glomerular injury, thrombotic microangiopathy and tubular cast formation were also decreased in captopril‐treated rats administered sorafenib. Renal autoregulatory efficiency was determined by evaluating the afferent arteriolar constrictor response to ATP . Sorafenib administration attenuated the vasoconstriction to ATP , whereas concurrent captopril treatment improved ATP reactivity. In conclusion, captopril attenuated hypertension and renal injury and improved renal autoregulatory capacity in rats administered sorafenib. These findings indicate that captopril treatment, in addition to alleviating the detrimental side‐effect of hypertension, decreases the renal injury associated with anticancer VEGF i therapies such as sorafenib." @default.
- W2151403254 created "2016-06-24" @default.
- W2151403254 creator A5001851791 @default.
- W2151403254 creator A5005298031 @default.
- W2151403254 creator A5020132788 @default.
- W2151403254 date "2012-04-23" @default.
- W2151403254 modified "2023-10-17" @default.
- W2151403254 title "Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib" @default.
- W2151403254 cites W1639582946 @default.
- W2151403254 cites W1815432645 @default.
- W2151403254 cites W1965261569 @default.
- W2151403254 cites W1969777154 @default.
- W2151403254 cites W1970725421 @default.
- W2151403254 cites W1976799641 @default.
- W2151403254 cites W1983070595 @default.
- W2151403254 cites W1986383169 @default.
- W2151403254 cites W1993064385 @default.
- W2151403254 cites W1997666894 @default.
- W2151403254 cites W2007012706 @default.
- W2151403254 cites W2009265227 @default.
- W2151403254 cites W2013811855 @default.
- W2151403254 cites W2021065154 @default.
- W2151403254 cites W2024946751 @default.
- W2151403254 cites W2036735258 @default.
- W2151403254 cites W2041739478 @default.
- W2151403254 cites W2045260833 @default.
- W2151403254 cites W2051563676 @default.
- W2151403254 cites W2052550764 @default.
- W2151403254 cites W2053830854 @default.
- W2151403254 cites W2061206303 @default.
- W2151403254 cites W2061878037 @default.
- W2151403254 cites W2062333149 @default.
- W2151403254 cites W2062744722 @default.
- W2151403254 cites W2066033677 @default.
- W2151403254 cites W2071979522 @default.
- W2151403254 cites W2085213066 @default.
- W2151403254 cites W2088235345 @default.
- W2151403254 cites W2093890508 @default.
- W2151403254 cites W2094027122 @default.
- W2151403254 cites W2095039099 @default.
- W2151403254 cites W2098870242 @default.
- W2151403254 cites W2101580559 @default.
- W2151403254 cites W2107661284 @default.
- W2151403254 cites W2115841084 @default.
- W2151403254 cites W2116665727 @default.
- W2151403254 cites W2117801955 @default.
- W2151403254 cites W2121534113 @default.
- W2151403254 cites W2122724278 @default.
- W2151403254 cites W2123421036 @default.
- W2151403254 cites W2125212831 @default.
- W2151403254 cites W2133302438 @default.
- W2151403254 cites W2141046053 @default.
- W2151403254 cites W2150893441 @default.
- W2151403254 cites W2158937156 @default.
- W2151403254 cites W2163212122 @default.
- W2151403254 cites W2164363535 @default.
- W2151403254 cites W2168524859 @default.
- W2151403254 cites W2170615524 @default.
- W2151403254 doi "https://doi.org/10.1111/j.1440-1681.2012.05699.x" @default.
- W2151403254 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3613249" @default.
- W2151403254 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22443474" @default.
- W2151403254 hasPublicationYear "2012" @default.
- W2151403254 type Work @default.
- W2151403254 sameAs 2151403254 @default.
- W2151403254 citedByCount "21" @default.
- W2151403254 countsByYear W21514032542013 @default.
- W2151403254 countsByYear W21514032542014 @default.
- W2151403254 countsByYear W21514032542015 @default.
- W2151403254 countsByYear W21514032542016 @default.
- W2151403254 countsByYear W21514032542017 @default.
- W2151403254 countsByYear W21514032542018 @default.
- W2151403254 countsByYear W21514032542019 @default.
- W2151403254 countsByYear W21514032542020 @default.
- W2151403254 countsByYear W21514032542022 @default.
- W2151403254 crossrefType "journal-article" @default.
- W2151403254 hasAuthorship W2151403254A5001851791 @default.
- W2151403254 hasAuthorship W2151403254A5005298031 @default.
- W2151403254 hasAuthorship W2151403254A5020132788 @default.
- W2151403254 hasBestOaLocation W21514032542 @default.
- W2151403254 hasConcept C126322002 @default.
- W2151403254 hasConcept C134018914 @default.
- W2151403254 hasConcept C167734588 @default.
- W2151403254 hasConcept C27016395 @default.
- W2151403254 hasConcept C2777025900 @default.
- W2151403254 hasConcept C2778019345 @default.
- W2151403254 hasConcept C2778695046 @default.
- W2151403254 hasConcept C2779479957 @default.
- W2151403254 hasConcept C71924100 @default.
- W2151403254 hasConcept C84393581 @default.
- W2151403254 hasConcept C98274493 @default.
- W2151403254 hasConceptScore W2151403254C126322002 @default.
- W2151403254 hasConceptScore W2151403254C134018914 @default.
- W2151403254 hasConceptScore W2151403254C167734588 @default.
- W2151403254 hasConceptScore W2151403254C27016395 @default.
- W2151403254 hasConceptScore W2151403254C2777025900 @default.
- W2151403254 hasConceptScore W2151403254C2778019345 @default.
- W2151403254 hasConceptScore W2151403254C2778695046 @default.
- W2151403254 hasConceptScore W2151403254C2779479957 @default.